Thoracic Cancer Trial

Lung Cancer, Non-Small Cell

Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 Non-Small Cell Lung Cancer

 

Physician and Research Staff Educational Material:

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

Information and Assistance from the National Cancer Institute:

    • Locations and other information
    • Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail.

Clinicaltrials.gov ID: NCT04092283

Return to Home Page | Review Other Active Trials